Bioorganic and Medicinal Chemistry Letters

Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P₁C gem-disubstitution
pp. 1443-1448(6)
Authors: Curtin M.L.; Garland R.B.; Davidsen S.K.; Marcotte P.A.; Albert D.H.; Magoc T.J.; Hutchins C.

Relationship between dihedral angles of N1 and C9 substituents in 1,4-Benzodiazepines and dual cholecystokinin-A and -B antagonistic activities
pp. 1449-1454(6)
Authors: Tabuchi S.; Nakanishi I.; Satoh Y.

Functionalization of a viscosity-sensitive fluorophore for probing of biological systems
pp. 1455-1460(6)
Authors: Petric A.; Jacobson A.F.; Barrio J.R.

5-alkyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series
pp. 1461-1466(6)
Authors: Vig R.; Mao C.; Venkatachalam T.K.; Tuel-Ahlgren L.; Sudbeck E.A.; Uckun F.M.

Inhibition of electric eel acetylcholinesterase by porphin compounds
pp. 1467-1470(4)
Authors: Lee B.H.; Park M.B.; Soo Yu B.

2(1H)-Quinolinone derivatives as novel anti-arteriostenotic agents showing anti-thrombotic and anti-hyperplastic activities
pp. 1471-1476(6)
Authors: Koga Y.; Kihara Y.; Okada M.; Inoue Y.; Tochizawa S.; Toga K.; Tachibana K.; Kimura Y.; Nishi T.; Hidaka H.

Peptidyl -homo-aspartals: specific inhibitors of interleukin-1 converting enzyme and its homologues (caspases)
pp. 1477-1482(6)
Authors: Bajusz S.; Fauszt I.; Nemeth K.; Barabas E.; Juhasz A.; Patthy M.

Anti-aids agents 31. Synthesis and anti-HIV activity of 4-substituted 3',4'-di-O-(-)-camphanoyl-(+)-Cis-Khellactone (DCK) thiolactone analogs
pp. 1483-1486(4)
Authors: Yang Z.-Y.; Xia Y.; Xia P.; Cosentino L.M.; Lee K.-H.

8-Aminoquinolines as anticoccidials - II
pp. 1487-1492(6)
Authors: Armer R.E.; Barlow J.S.; Dutton C.J.; Greenway D.H.J.; Greenwood S.D.W.; Lad N.; Thompson A.P.; Thong K.-W.; Tommasini I.

N-[4-(1,1'-biphenyl)methyl]-4-(4-thiomorpholinylmethyl) benzenamines as non-oxazolidinone analogues of antimycobacterial U-100480
pp. 1493-1498(6)
Authors: Artico M.; Mai A.; Sbardella G.; Massa S.; Lampis G.; Deidda D.; Pompei R.

Isoindolinone enantiomers having affinity for the dopamine D₄ receptor
pp. 1499-1502(4)
Authors: Belliotti T.R.; Brink W.A.; Kesten S.R.; Rubin J.R.; Wustrow D.J.; Zoski K.T.; Whetzel S.Z.; Corbin A.E.; Pugsley T.A.; Heffner T.G.; Wise L.D.

Syntheses of two enantiomeric pairs of myo-inositol(1,2,4,5,6) and -(1,2,3,4,5) pentakisphosphate
pp. 1503-1506(4)
Authors: Chung S.-K.; Chang Y.-T.; Eun J.L.; Shin B.-G.; Kwon Y.-U.; Kim K.-C.; Dong H.L.; Kim M.-J.

Synthesis and Pharmacological Activities of 13-Dehydro Derivatives of Primary Prostaglandins
pp. 1507-1510(4)
Authors: Tanami T.; Kameo K.; Ono N.; Nakagawa T.; Annou S.; Tsuboi M.; Tani K.; Okamoto S.; Sato F.

Synthesis and anti-HIV activities of urea-PETT analogs belonging to a new class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors
pp. 1511-1516(6)
Authors: Sahlberg C.; Noreen R.; Engelhardt P.; Hogberg M.; Kangasmetsa J.; Vrang L.; Hong Z.

Synthesis of protected guanidinium linked dinucleoside incorporable into an oligonucleotide using solid phase DNA methodology
pp. 1517-1520(4)
Authors: Barawkar D.A.; Linkletter B.; Bruice T.C.

Evaluation of phosphorus-containing inhibitors of -glutamyl hydrolase
pp. 1521-1524(4)
Authors: Rodriguez C.E.; Holmes H.M.; Mlodnosky K.L.; Lam V.Q.; Berkman C.E.

Synthesis and in vitro cytotoxicity of lipophilic platinum(II) complexes
pp. 1525-1530(6)
Authors: Kokotos G.; Theodorou V.; Constantinou-Kokotou V.; Gibbons W.A.; Roussakis C.

Design and Synthesis of an Orally Active GPIIb/IIIa Antagonist Based on a Phenylpiperazine Scaffold
pp. 1531-1536(6)
Authors: van Maarseveen J.H.; den Hartog J.A.J.; Tipker K.; Reinders J.-H.; Brakkee J.; Schon U.; Kehrbach W.; Kruse C.G.

A Potent Dipeptide Inhibitor of Dipeptidyl Peptidase IV
pp. 1537-1540(4)
Authors: Yamada M.; Okagaki C.; Higashijima T.; Tanaka S.; Ohnuki T.; Sugita T.

Synthesis and NK₁ Receptor Antagonistic Activity of (+/-)-1-Acyl-3-(3,4-dichlorophenyl)-3-[2-(spiro-substituted piperidin-1'-yl)ethyl]piperidines
pp. 1541-1546(6)
Authors: Kubota H.; Okamoto Y.; Fujii M.; Ikeda K.; Takeuchi M.; Shibanuma T.; Isomura Y.

Synthesis and antitumor activity of 4-phenyl-1-arylsulfonyl imidazolidinones
pp. 1547-1550(4)
Authors: Jung S.-H.; Lee H.-S.; Song J.-S.; Kim H.-M.; Han S.-B.; Lee C.-W.; Moonsun L.; Choi D.-R.; Lee J.-A.; Chung Y.-H.; Yoon S.-J.; Moon E.-Y.; Hwang H.-S.; Seong S.-K.; Lee D.-K.

Synthesis of N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)nicotinamides and their affinities for 5-HT₃ and dopamine D₂ receptors
pp. 1551-1554(4)
Authors: Hirokawa Y.; Yoshida N.; Kato S.

Modulation of multidrug resistance by Taxuspine C and other taxoids from Japanese yew
pp. 1555-1558(4)
Authors: Kobayashi J.; Hosoyama H.; Wang X.-x.; Shigemori H.; Sudo Y.; Tsuruo T.

A New Class of Sulfoxide Surfactants derived from Tris. Synthesis and Preliminary Assessments of their Properties
pp. 1559-1562(4)
Authors: Barthelemy P.; Maurizis J.C.; Lacombe J.M.; Pucci B.

Synthesis and pharmacology of N-alkylated derivatives of the excitotoxin ibotenic acid
pp. 1563-1568(6)
Authors: Madsen U.; Dumpis M.A.; Brauner-Osborne H.; Piotrovsky L.B.

Synthesis and preliminary evaluation of (S)-2-(4'-carboxycubyl)glycine, a new selective mGluR1 antagonist
pp. 1569-1574(6)
Authors: Pellicciari R.; Costantino G.; Giovagnoni E.; Mattoli L.; Brabet I.; Pin J.-P.

On the Preparative Use of Recombinant Pig (1-3)Galactosyl-Transferase
pp. 1575-1578(4)
Authors: Baisch G.; Ohrlein R.; Kolbinger F.; Streiff M.